Search Results 811-820 of 16318 for monoclonal antibody

  1. MEDI5395 Advanced Solid Tumors - Mayo Clinic

    At least 28 days must have elapsed since non-immunotherapy monoclonal antibody treatment (for example trastuzumab, cetuximab, bevacizumab, or panitumumab); ...

  2. A Study to Determine Number of Rounds of Plasma Exchange Needed to Decrease Measles Virus Antibodies for Measles Virus Cancer Therapy - Mayo Clinic

    The purpose of this study is to determine how many rounds of plasma exchange are required for maximal decrease in measles antibodies and how long it may last, ...

  3. A Study Evaluating the Effectiveness and Safety of Axicabtagene Ciloleucel in Subjects with High-Risk Large B-Cell Lymphoma - Mayo Clinic

    2 cycles of an anti-CD20 monoclonal antibody (unless investigator determines that tumor is CD20 negative) and anthracycline-containing regimen (e.g., DA ...

  4. Mayo Clinic Podcast - Dr. Gregory Poland - YouTube audio exp...

    those antibodies. There are antiviral drugs like remdesivir, there are monoclonal antibody drugs that are being developed. Right now, the ones that are ...

  5. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

    History of severe hypersensitivity reaction to any monoclonal antibody. Prior malignancy active within the previous 3 years except for locally potentially ...

  6. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

    ... antibody must be negative for HCV RNA by PCR to be eligible for study participation ... Monoclonal and/or bispecific antibodies or CAR T - At least 28 days. 5 ...

  7. A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants - Mayo Clinic

    ... monoclonal antibody (mAb) and for which no other more appropriate treatment option exists; At least one bidimensionally measurable lesion; Agreement to remain ...

  8. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

    Chemotherapy, small molecule inhibitors, radiation, and/or other investigational anticancer agents (excluding investigational monoclonal antibodies): within 2 ...

  9. A Study to Evaluate the Effectiveness and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients - Mayo Clinic

    The purpose of this study is to investigate how efficiently the study medication imlifidase reduces the amount of donor specific antibodies (DSA) in comparison ...

  10. ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer - Mayo Clinic

    Prior antibody treatment for cancer must have been ... Sacituzumab govitecan-hziy is an antibody-drug conjugate that combines a humanized monoclonal ...